Akero Therapeutics, Inc.
Industry: Life Sciences ・ $AKRO on Nasdaq
Insider Sale
+$1,206,000
-12.26%
Shares
Shares Volume: 40,000 Shares
Average Share Price: $30.15
INSIDER
Young Jonathan
Chief Operating Officer (Officer)
reported on Oct 16 2024
traded on Oct 14 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 286,286 |
| PURCHASES/SALES 1Y | 0 / 13 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $219,354.9 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 2 / 37 |
| P/S VALUE RATIO | 0.22 |
| AVERAGE SALE VALUE | $451,859.18 |
| COMPANY PREVIOUS TRADES |